The study objective was to evaluate the potential prognostic significance of WNT5A genes as diagnostic biomarkers for various types of cancer, such as glioblastoma (GMB), lung squamous cell carcinoma (LUSC), and lung adenocarcinoma (LUAD). This evidence concerns the gene WNT5A and squamous cell lung carcinoma.